PARTICULARS OF MATTERS TO BE ACTED UPON
1. Approval of Control Person
Background of
Uranium Energy
On January 14, 2025, the Company announced that it had entered into a subscription agreement with Uranium Energy, a public
company listed on the NYSE American, whereby Uranium Energy agreed to acquire 104,142,857 Common Shares at a price of $0.14 per Common Shares for total gross proceeds of $15,000,000, which such financing closed on January 15, 2025.
On February 20, 2025, the Company entered into an indemnification support agreement with Uranium Energy whereby Uranium Energy agreed to provide
indemnification support limited to US$3,000,000 (the “Support Amount”) in connection with certain bonding requirements relating to Shootaring Canyon Mill. In consideration for the provision of the indemnity, the Company agreed to
pay to Uranium Energy a cash support fee equal to the Support Amount multiplied by the secured overnight financing rate as administered by the CME Group Benchmark Administration Limited plus 5% per annum, which fee is to be calculated monthly and
paid in US dollars in arrears on the first day of each calendar month. The Company also agreed to grant Uranium Energy certain board nomination rights as well as anti-dilution and pre-emptive rights, pursuant
to which Uranium Energy may subscribe for and be issued up to such number of Common Shares that will allow Uranium Energy to maintain its percentage ownership interest in the Company.
On June 20, 2025, enCore Energy Corp. sold 170,000,000 Common Shares (on a pre-consolidation basis) to Uranium
Energy pursuant to a private sale transaction, bringing Uranium Energy’s shareholdings in the Company to 32.4% of the then outstanding Common Shares of the Company (the “Acquisition”). Following closing of the Acquisition,
Uranium Energy was deemed to have become a “Control Person” of the Company, as defined in the TSX Venture Exchange Corporate Finance Manual (the “TSXV Manual”), because it owned more than 20% of the outstanding
Common Shares of the Company.
On December 24, 2025, the Company announced that it was undertaking a
non-brokered private placement of 1,345,292 Common Shares of the Company, at a price of US$4.46 per Common Share, to raise gross proceeds of US$6,000,000 (the “LIFE Offering”). The Company
also announced an undertaking of a concurrent non-brokered private placement for the issuance of 896,861 subscription receipts (the “Subscription Receipts”) to UEC Energy Corp.
(“UEC”), a wholly-owned subsidiary of Uranium Energy, at a price of US$4.46 per Subscription Receipt, for gross proceeds of US$4,000,000 (the “Concurrent Offering”).
Each Subscription Receipt entitles UEC, a wholly-owned subsidiary of Uranium Energy, to receive, upon satisfaction of the Escrow Release Conditions (as
defined below) on or prior to 5:00 p.m. (Vancouver time) on March 31, 2026 or such other later date as may be specified by UEC in writing, one Common Share in the capital of the Company (each, a “Subscription Receipt Share”),
without payment of additional consideration and without further action on the part of UEC. The Company requires the approval of the TSX Venture Exchange (the “TSXV”) of the participation of Uranium Energy through its wholly-owned
subsidiary, UEC, in the Concurrent Offering and, pursuant to the TSXV Manual, the approval of the disinterested shareholders of the Company of Uranium Energy as a “Control Person” of the Company (as such term is defined by the TSXV
Manual) by at least a simple majority of the votes cast at the Meeting, excluding votes attached to Common Shares held by Uranium Energy and its “Associates” and “Affiliates” (as such terms are defined by the TSXV Manual)
(the “Escrow Release Conditions”).
On January 12, 2026, the Company announced the closing of the LIFE Offering and the Concurrent
Offering.
8